Cancer patient stratification based on the tumor microenvironment.
作者信息
Ying Le, Yan Feng, Xu Dakang
机构信息
Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
出版信息
J Thorac Dis. 2020 Aug;12(8):4522-4526. doi: 10.21037/jtd.2020.03.77.
Abstract
摘要
相似文献
1
Cancer patient stratification based on the tumor microenvironment.基于肿瘤微环境的癌症患者分层
J Thorac Dis. 2020 Aug;12(8):4522-4526. doi: 10.21037/jtd.2020.03.77.
2
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.基于肿瘤和微环境特征的胰腺导管腺癌分层。
Gastroenterology. 2018 Dec;155(6):1999-2013.e3. doi: 10.1053/j.gastro.2018.08.033. Epub 2018 Aug 27.
3
Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.基于肿瘤微环境的预后评分在原发性可切除结直肠癌中的评估。
Clin Cancer Res. 2015 Feb 15;21(4):882-8. doi: 10.1158/1078-0432.CCR-14-1686. Epub 2014 Dec 3.
4
A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy.结直肠癌肿瘤微环境概述：液体活检。
Int J Mol Sci. 2019 Nov 29;20(23):6016. doi: 10.3390/ijms20236016.
5
Revisiting ovarian cancer microenvironment: a friend or a foe?重新审视卵巢癌微环境：是敌是友？
Protein Cell. 2018 Aug;9(8):674-692. doi: 10.1007/s13238-017-0466-7. Epub 2017 Sep 19.
6
Immunophenotypes Based on the Tumor Immune Microenvironment Allow for Unsupervised Penile Cancer Patient Stratification.基于肿瘤免疫微环境的免疫表型可实现阴茎癌患者的无监督分层。
Cancers (Basel). 2020 Jul 4;12(7):1796. doi: 10.3390/cancers12071796.
7
Tumor microenvironment determines response to a heat-activated thermosensitive liposome formulation of cisplatin in cervical carcinoma.肿瘤微环境决定了顺铂热激活热敏脂质体制剂在宫颈癌中的反应。
J Control Release. 2017 Sep 28;262:182-191. doi: 10.1016/j.jconrel.2017.07.039. Epub 2017 Jul 29.
8
Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer.化疗对改善胰腺癌肿瘤微环境的临床影响。
World J Gastrointest Oncol. 2016 Nov 15;8(11):786-792. doi: 10.4251/wjgo.v8.i11.786.
9
Role of Immune Microenvironmental Factors for Improving the IPI-related Risk Stratification of Aggressive B Cell Lymphoma.免疫微环境因素在改善侵袭性B细胞淋巴瘤IPI相关风险分层中的作用
Biomed Environ Sci. 2017 Jul;30(7):492-500. doi: 10.3967/bes2017.065.
10
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.弥漫性脑世界卫生组织分级 II/III 级神经胶质瘤的 DNA 甲基化、转录组和遗传拷贝数特征解析肿瘤异质性和发生。
Acta Neuropathol Commun. 2019 Apr 25;7(1):59. doi: 10.1186/s40478-019-0704-8.
引用本文的文献
1
Stromal Expression Profiling Reveals Immune-Driven Adaption to Malignancy in Canine Melanoma Subtypes.基质表达谱揭示犬黑色素瘤亚型中免疫驱动的恶性肿瘤适应性变化
Vet Comp Oncol. 2025 Mar;23(1):20-29. doi: 10.1111/vco.13021. Epub 2024 Oct 17.
2
Lipid-based nanosystems: the next generation of cancer immune therapy.基于脂质的纳米系统：下一代癌症免疫治疗。
J Hematol Oncol. 2024 Jul 19;17(1):53. doi: 10.1186/s13045-024-01574-1.
3
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy.CD40 激动剂 HERA-CD40L 可增强抗原呈递细胞的激活，单独使用和与放射治疗联合使用均可发挥抗肿瘤作用。
Front Immunol. 2023 May 26;14:1160116. doi: 10.3389/fimmu.2023.1160116. eCollection 2023.
4
Perspectives and challenges in patient stratification in Alzheimer's disease.阿尔茨海默病患者分层的观点与挑战。
Alzheimers Res Ther. 2022 Aug 13;14(1):112. doi: 10.1186/s13195-022-01055-y.
本文引用的文献
1
Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.肿瘤浸润 CD8+ 和 FoxP3+ 淋巴细胞的联合评估可为 IA 期肺腺癌提供准确的预后。
Ann Surg Oncol. 2020 Jun;27(6):2102-2109. doi: 10.1245/s10434-019-08029-9. Epub 2019 Nov 26.
2
Tissue-specific tumor microenvironments influence responses to immunotherapies.组织特异性肿瘤微环境影响对免疫疗法的反应。
Clin Transl Immunology. 2019 Nov 21;8(11):e1094. doi: 10.1002/cti2.1094. eCollection 2019.
3
The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD-L1 expression and tumor-infiltrating lymphocytes.基于 PD-L1 表达和肿瘤浸润淋巴细胞的肺腺癌和鳞状细胞癌免疫微环境景观。
Cancer Med. 2019 Dec;8(17):7207-7218. doi: 10.1002/cam4.2580. Epub 2019 Oct 11.
4
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.纳武利尤单抗联合伊匹单抗治疗晚期非小细胞肺癌。
N Engl J Med. 2019 Nov 21;381(21):2020-2031. doi: 10.1056/NEJMoa1910231. Epub 2019 Sep 28.
5
Genomic correlates of response to immune checkpoint blockade.免疫检查点阻断治疗反应的基因组相关性。
Nat Med. 2019 Mar;25(3):389-402. doi: 10.1038/s41591-019-0382-x. Epub 2019 Mar 6.
6
Tissue-resident memory CD8 T cells promote melanoma-immune equilibrium in skin.组织驻留记忆 CD8 T 细胞促进皮肤中的黑色素瘤免疫平衡。
Nature. 2019 Jan;565(7739):366-371. doi: 10.1038/s41586-018-0812-9. Epub 2018 Dec 31.
7
Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis.髓源性抑制细胞在癌症中的预后作用：系统评价和荟萃分析。
BMC Cancer. 2018 Dec 5;18(1):1220. doi: 10.1186/s12885-018-5086-y.
8
Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.PD-L1 表达和 CD8+T 细胞浸润在 EGFR 突变和 ALK 重排肺癌患者中的临床意义。
Lung Cancer. 2018 Nov;125:86-92. doi: 10.1016/j.lungcan.2018.09.010. Epub 2018 Sep 14.
9
The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis.免疫检查点抑制剂联合疗法治疗肺癌的疗效与安全性：一项系统评价与Meta分析
Onco Targets Ther. 2018 Oct 24;11:7369-7383. doi: 10.2147/OTT.S177318. eCollection 2018.
10
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization.癌症免疫治疗的范式转变：从增强到正常化。
Cell. 2018 Oct 4;175(2):313-326. doi: 10.1016/j.cell.2018.09.035.
Zotero 插件